Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval crawled time : 06:00 save search
argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia
Published: 2024-03-26 (Crawled : 06:00) - globenewswire.com
ARGX | $368.75 2.37% 2.38% 310K
|
Health Technology
|
| O: 0.07%
H: 0.79%
C: -0.29%
japan vyvgart approval
argenx Announces Approval of VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis
Published: 2024-01-18 (Crawled : 06:00) - globenewswire.com
ARGX | $368.75 2.37% 2.38% 310K
|
Health Technology
|
| O: -0.63%
H: 0.17%
C: -1.16%
vyvdura japan approval injection
Teck Receives Regulatory Approval for Share Buy-Back Program
Published: 2023-11-20 (Crawled : 06:00) - globenewswire.com
TECK | $45.86 -2.7% -1.13% 5.5M
|
Non-Energy Minerals
|
| O: 1.47%
H: 1.09%
C: -0.44%
approval program
Everest Medicines Announces New Drug Application Approval by the Pharmaceutical Administration Bureau of Macau for Nefecon® for the Treatment of Primary IgA Nephropathy
Published: 2023-10-27 (Crawled : 06:00) - prnewswire.com
PFE | News A | $26.26 1.0% 0.38% 29M
|
Health Technology
|
| O: -0.32%
H: 0.23%
C: -3.06%
nefecon nephropathy drug approval treatment application
Sandoz receives European Commission approval for Tyruko® (natalizumab), first and only biosimilar for multiple sclerosis in Europe
Published: 2023-09-26 (Crawled : 06:00) - globenewswire.com
NVSEF | News | $95.11 5.4% 6.88% 490
|
Health Technology
|
| O: -3.05%
H: 1.75%
C: 0.5%
NVS | News | $95.12 0.81% 5.43% 2.3M
|
Health Technology
|
| O: -0.07%
H: 0.46%
C: -0.31%
tyruko europe biosimilar approval sclerosis
Sandoz receives FDA approval for Tyruko® (natalizumab-sztn), first and only FDA-approved biosimilar for relapsing forms of multiple sclerosis
Published: 2023-08-25 (Crawled : 06:00) - globenewswire.com
NVS | News | $95.12 0.81% 5.43% 2.3M
|
Health Technology
|
| O: 0.67%
H: 0.37%
C: 0.26%
tyruko fda biosimilar approval sclerosis
AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Preventive Treatment of Migraine in Adults
Published: 2023-08-17 (Crawled : 06:00) - prnewswire.com
ABBV | News | $167.89 0.89% 0.51% 3.6M
|
Health Technology
|
| O: -0.87%
H: 0.49%
C: -0.75%
aquipta abbvie approval treatment migraine
Beard Energy Transition Acquisition Corp. Announces Stockholder Approval of Proposals at Special Meeting – Yahoo Finance
Published: 2023-05-25 (Crawled : 06:00) - spacfeed.com
LAZR 4 | $1.3 -0.76% -1.55% 5.1M
|
|
| O: -0.61%
H: 5.21%
C: 2.3%
energy approval acquisition meeting
Sale of Clear Channel Outdoor Holdings, Inc.'s Switzerland Business Receives Regulatory Approval
Published: 2023-03-09 (Crawled : 06:00) - prnewswire.com
MS | News 0 d | $92.09 1.58% 0.07% 4.9M
|
Finance
|
| O: -0.56%
H: 0.62%
C: -3.31%
CCO | $1.47 -1.34% 0.0% 1.4M
|
Commercial Services
|
| O: -0.68%
H: 0.68%
C: -7.48%
approval switzerland
Astellas Receives SBTi Approval for Revised Science-Based Climate Goals to Reduce Greenhouse Gas Emissions
Published: 2023-01-19 (Crawled : 06:00) - prnewswire.com
ALPMY | News | $9.53 0.32% -1.11% 690K
|
Manufacturing
|
| O: 0.2%
H: 0.0%
C: -0.46%
approval
InnoCare Announces Approval of Tafasitamab in Combination With Lenalidomide for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Hong Kong
Published: 2022-12-28 (Crawled : 06:00) - biospace.com/
XNCR | $18.21 -0.93% -1.04% 510K
|
Health Technology
|
| O: -0.36%
H: 2.46%
C: -1.47%
MOR | News | $17.96 -0.11% -0.06% 320K
|
Health Technology
|
| O: 0.0%
H: 1.71%
C: 0.93%
treatment approval
Bavarian Nordic Receives European Approval of Extension of Vaccine Label to Include Monkeypox
Published: 2022-07-25 (Crawled : 06:00) - globenewswire.com
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
monkeypox label vaccine extension approval
Ericsson receives regulatory approval to complete acquisition of Vonage
Published: 2022-07-15 (Crawled : 06:00) - prnewswire.com
VG | $20.99 0.0%
|
Communications
|
| O: 8.04%
H: 0.14%
C: 0.1%
ERIC | News | $5.26 3.14% 2.86% 23M
|
Electronic Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
acquisition approval
Global Panic Disorders Market Insights | Size | Shares | Trends | Growth | Industry Analysis [2020-2030] Panic disorders, also known as anxiety disorder deals with recurrent and unexpected panic attacks. PET-CT Scanner Devices Market: Competitive Landscape Analysis With Forecast by 2031 Wilmington, Delaware: According to the report, the global PET-CT scanner devices market was valued over US$ 200 Mn in 2020 and is projected to expand at a CAGR of ~3% from 2021 to 2031. Portal Hypertension Market Insights | Current Trends | Growth Opportunity | Global Industry Analysis [2020-2030] At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. Spatial Genomics & Transcriptomics Market to Experience Significant Growth by 2027 Wilmington, Delaware: The spatial genomics & transcriptomics market is prognosticated to bring profitable growth during the assessment period of 2019-2027. Teleradiology Services Market to Make Great Impact in Near Future by 2031 Wilmington, Delaware: According to the report, the global teleradiology services market was valued over US$ 6.4 Bn in 2020. Anti-depressants Drugs and Therapies Market to Witness a Pronounce Growth by 2025 Wilmington, Delaware: Anti-depressants medications lower the symptoms of depression, dysthymia, chronic depression, and anxiety disorders. B-Cell Non-Hodgkin’s Lymphoma (NHL) Market to Offer Ample Growth Opportunities by 2027 Wilmington, Delaware: Non-Hodgkin’s lymphoma is a group of heterogeneous proliferative malignancies. Heightening Healthcare Spending Opening Growth Avenues for Collateral Ligament Stabilizer System Market, Reaching US$ 3.5 Billion in 2032: Fact.MR Study Fact.MR – A Market Research and Competitive Intelligence Provider: The global collateral ligament stabilizer system market is expected to reach US$ 3.5 Billion by the end of the 2022-2032 forecast period, growing at a CAGR of 6.1%, concludes a recently published report by Fact.MR. Breast Cancer Liquid Biopsy Market Trends, Growth, Analysis and Future Scope, 2026 Wilmington, Delaware: A biopsy is a tissue or cell sample taken from any part of the patient’s body and examined in the lab for the detection of cancer. Cerebral Palsy Market Size, Shares, Trends and Growth | Global Industry Analysis [2020-2030] The global cerebral palsy market is picking up steam due to increasing awareness about the condition amongst parents. Continuous Glucose Monitoring Market: Competitive Research and Precise Outlook 2021 to 2028 Wilmington, Delaware: The global continuous glucose monitoring market depicts the presence of a large competitive vendor landscape, says Transparency Market Research on the basis of a newly research report. Crow’s Feet Market Key Trends and Opportunity Analysis up to 2026 Albany NY, United States: The demand within the global crow’s feet market has been escalating on account of vital advancements in the field of dermatology in recent times. HIV Associated Lipodystrophy Syndrome Market Insights | Global Industry Analysis [2020-2030] HIV-associated lipodystrophy is a syndrome that are found in human immune-deficiency virus -infected patients who are being administered with active antiretroviral medications for the treatment of HIV infection. Global Mail Service Pharmacy Market | Size | Shares | Trends | Growth | Forecast [2020-2030]
Published: 2022-06-03 (Crawled : 06:00) - biospace.com/
GLAXF | News | $20.305 0.52% -14.18% 630
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 77
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
AZNCF | News | $138.73 1.86% -4.19% 3.6K
|
Health Technology
|
| O: -0.4%
H: 4.05%
C: -1.35%
PFE | News A | $26.26 1.0% 0.38% 29M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
GSK | News | $40.59 2.11% 0.57% 3.5M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
LLY | News | $731.33 0.69% 0.36% 1.7M
|
Health Technology
|
| O: -2.25%
H: 0.0%
C: 0.0%
BMY | $49.14 0.43% 0.2% 6.4M
|
Health Technology
|
| O: -1.4%
H: 0.0%
C: 0.0%
SNY | News | $47.15 1.84% 1.75% 2M
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
NBIX | News M | $133.66 1.26% 1.12% 460K
|
Health Technology
|
| O: 2.29%
H: 0.0%
C: 0.0%
AZN | News | $70.13 2.31% 2.24% 4.3M
|
Health Technology
|
| O: -0.56%
H: 0.82%
C: -0.64%
lipodystrophy treatment research system active services report service growing hiv profitable hypertension genomics expected virus approval cancer growth group market breast cancer infections
Takeda Announces Approval of Nuvaxovid® COVID-19 Vaccine for Primary and Booster Immunization in Japan
Published: 2022-04-19 (Crawled : 06:00) - biospace.com/
TAK | News | $13.36 0.91% 0.0% 1.5M
|
Health Technology
|
| O: -2.23%
H: 0.0%
C: 0.0%
covid-19 nuvaxovid vaccine approval
Novartis expands Zolgensma manufacturing capacity with approval of multi-product North Carolina facility
Published: 2022-04-05 (Crawled : 06:00) - globenewswire.com
NVS | News | $95.12 0.81% 5.43% 2.3M
|
Health Technology
|
| O: 0.57%
H: 0.79%
C: 0.39%
novartis approval
Futu Holdings' Subsidiary, Futu Singapore Received Multiple Approvals-in-Principle and Exempt Financial Adviser Status Regarding Trading, Clearing, and Investment Advisory in Singapore
Published: 2022-02-10 (Crawled : 06:00) - globenewswire.com
FUTU | $55.55 1.42% 1.4% 920K
|
Technology Services
|
| O: -0.85%
H: 8.7%
C: 1.15%
als approval
Baidu Apollo Wins Approval for Commercialized Autonomous Car Service on Open Roads in Beijing
Published: 2021-11-25 (Crawled : 06:00) - prnewswire.com
BIDU | $97.24 2.3% 2.25% 2.7M
|
Technology Services
| Email alert
Add to watchlist
SNY | News | $47.15 1.84% 1.75% 2M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 77
|
Health Technology
| Email alert
Add to watchlist
autonomous approval commercialization
Medtronic Receives CE Mark Approval for Radial Artery Access Portfolio
Published: 2021-09-28 (Crawled : 06:00) - prnewswire.com
MDT | $80.57 1.37% 0.0% 3.8M
|
Health Technology
|
| O: -0.73%
H: 0.1%
C: -1.42%
ce mark approval
Eisai Initiates Rolling Submission To The U.S. FDA For Biologics License Application Of Lecanemab (BAN2401) For Early Alzheimer's Disease Under The Accelerated Approval Pathway
Published: 2021-09-28 (Crawled : 06:00) - biospace.com/
BIIB | $194.11 -0.14% -0.15% 930K
|
Health Technology
|
| O: 1.47%
H: 0.25%
C: -2.1%
disease alzheimer fda license approval submission alzheimer’s alzheimer's disease alzheimer's lecanemab
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
PROK | $2.72 33.33% 24.58% 2.6M
|
Your saved searches
Save your searches and get alerts when important news are released.